Does a web-based decision aid improve informed choice for fertility preservation in women with breast cancer (DECISIF)? Study protocol for a randomised controlled trial

IntroductionChemotherapy may cause infertility in young survivors of breast cancer. Various fertility preservation techniques increase the likelihood of survivors becoming genetic mothers. Disclosure of cancer diagnosis may impact decision making about fertility preservation. This protocol will deve...

Full description

Bibliographic Details
Main Authors: Alexandra Benoit, Michael Grynberg, Rémy Morello, Nathalie Sermondade, Guillaume Grandazzi, Grégoire Moutel
Format: Article
Language:English
Published: BMJ Publishing Group 2020-02-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/2/e031739.full
_version_ 1819114406763560960
author Alexandra Benoit
Michael Grynberg
Rémy Morello
Nathalie Sermondade
Guillaume Grandazzi
Grégoire Moutel
author_facet Alexandra Benoit
Michael Grynberg
Rémy Morello
Nathalie Sermondade
Guillaume Grandazzi
Grégoire Moutel
author_sort Alexandra Benoit
collection DOAJ
description IntroductionChemotherapy may cause infertility in young survivors of breast cancer. Various fertility preservation techniques increase the likelihood of survivors becoming genetic mothers. Disclosure of cancer diagnosis may impact decision making about fertility preservation. This protocol will develop and test the effectiveness of a web-based decision aid for helping women with breast cancer to make well-informed choices about fertility preservation.Methods and analysisThis study will be conducted in three phases using mixed methods. In phase I, the aim is to develop a web-based patient decision aid (PDA) in French with a steering committee and using a focus group of five women already treated for breast cancer. In phase II, the face validity of the decision aid will be assessed using questionnaires. In phase III, the PDA will be assessed by a two-arm randomised controlled trial. This will involve a quantitative evaluation of the PDA in clinical practice comparing the quality of the decision-making process between usual care and the PDA. The primary outcome will be informed choice and its components. The secondary outcomes will be decisional conflict and anxiety. Data will be collected during and after an oncofertility consultation. Phase III is underway. Since September 2018, 52 participants have been enrolled in the study and have completed the survey. We expect to have results by February 2020 for a total of 186 patients.Ethics and disseminationThis study protocol was approved by the Ouest V Research Ethics Board. Results will be spread through peer-reviewed publications, and reported at suitable meetings.Trial registration numberThe ClinicalTrials.gov registry .(NCT03591848).
first_indexed 2024-12-22T04:44:48Z
format Article
id doaj.art-79cbda9ea8344f6bbafc10d7a690748e
institution Directory Open Access Journal
issn 2044-6055
language English
last_indexed 2024-12-22T04:44:48Z
publishDate 2020-02-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj.art-79cbda9ea8344f6bbafc10d7a690748e2022-12-21T18:38:39ZengBMJ Publishing GroupBMJ Open2044-60552020-02-0110210.1136/bmjopen-2019-031739Does a web-based decision aid improve informed choice for fertility preservation in women with breast cancer (DECISIF)? Study protocol for a randomised controlled trialAlexandra Benoit0Michael Grynberg1Rémy Morello2Nathalie Sermondade3Guillaume Grandazzi4Grégoire Moutel51 UNICAEN, Inserm U1086, ANTICIPE, Normandie Université, Caen, France 2 Department of Reproductive Medicine and Fertility Preservation, Hôpital Antoine-Béclère, Clamart, France Department of research, University Hospital of Caen, Normandy, France6 Department of Cytogenetic and Reproductive Biology, Hôpital Jean Verdier, Bondy, France4 UNICAEN, Inserm U1086, ANTICIPE, Normandie Universite, Caen, France 4 UNICAEN, Inserm U1086, ANTICIPE, Normandie Universite, Caen, France IntroductionChemotherapy may cause infertility in young survivors of breast cancer. Various fertility preservation techniques increase the likelihood of survivors becoming genetic mothers. Disclosure of cancer diagnosis may impact decision making about fertility preservation. This protocol will develop and test the effectiveness of a web-based decision aid for helping women with breast cancer to make well-informed choices about fertility preservation.Methods and analysisThis study will be conducted in three phases using mixed methods. In phase I, the aim is to develop a web-based patient decision aid (PDA) in French with a steering committee and using a focus group of five women already treated for breast cancer. In phase II, the face validity of the decision aid will be assessed using questionnaires. In phase III, the PDA will be assessed by a two-arm randomised controlled trial. This will involve a quantitative evaluation of the PDA in clinical practice comparing the quality of the decision-making process between usual care and the PDA. The primary outcome will be informed choice and its components. The secondary outcomes will be decisional conflict and anxiety. Data will be collected during and after an oncofertility consultation. Phase III is underway. Since September 2018, 52 participants have been enrolled in the study and have completed the survey. We expect to have results by February 2020 for a total of 186 patients.Ethics and disseminationThis study protocol was approved by the Ouest V Research Ethics Board. Results will be spread through peer-reviewed publications, and reported at suitable meetings.Trial registration numberThe ClinicalTrials.gov registry .(NCT03591848).https://bmjopen.bmj.com/content/10/2/e031739.full
spellingShingle Alexandra Benoit
Michael Grynberg
Rémy Morello
Nathalie Sermondade
Guillaume Grandazzi
Grégoire Moutel
Does a web-based decision aid improve informed choice for fertility preservation in women with breast cancer (DECISIF)? Study protocol for a randomised controlled trial
BMJ Open
title Does a web-based decision aid improve informed choice for fertility preservation in women with breast cancer (DECISIF)? Study protocol for a randomised controlled trial
title_full Does a web-based decision aid improve informed choice for fertility preservation in women with breast cancer (DECISIF)? Study protocol for a randomised controlled trial
title_fullStr Does a web-based decision aid improve informed choice for fertility preservation in women with breast cancer (DECISIF)? Study protocol for a randomised controlled trial
title_full_unstemmed Does a web-based decision aid improve informed choice for fertility preservation in women with breast cancer (DECISIF)? Study protocol for a randomised controlled trial
title_short Does a web-based decision aid improve informed choice for fertility preservation in women with breast cancer (DECISIF)? Study protocol for a randomised controlled trial
title_sort does a web based decision aid improve informed choice for fertility preservation in women with breast cancer decisif study protocol for a randomised controlled trial
url https://bmjopen.bmj.com/content/10/2/e031739.full
work_keys_str_mv AT alexandrabenoit doesawebbaseddecisionaidimproveinformedchoiceforfertilitypreservationinwomenwithbreastcancerdecisifstudyprotocolforarandomisedcontrolledtrial
AT michaelgrynberg doesawebbaseddecisionaidimproveinformedchoiceforfertilitypreservationinwomenwithbreastcancerdecisifstudyprotocolforarandomisedcontrolledtrial
AT remymorello doesawebbaseddecisionaidimproveinformedchoiceforfertilitypreservationinwomenwithbreastcancerdecisifstudyprotocolforarandomisedcontrolledtrial
AT nathaliesermondade doesawebbaseddecisionaidimproveinformedchoiceforfertilitypreservationinwomenwithbreastcancerdecisifstudyprotocolforarandomisedcontrolledtrial
AT guillaumegrandazzi doesawebbaseddecisionaidimproveinformedchoiceforfertilitypreservationinwomenwithbreastcancerdecisifstudyprotocolforarandomisedcontrolledtrial
AT gregoiremoutel doesawebbaseddecisionaidimproveinformedchoiceforfertilitypreservationinwomenwithbreastcancerdecisifstudyprotocolforarandomisedcontrolledtrial